Navigation Links
Sinovac Reports Unaudited Third Quarter 2013 Financial Results
Date:11/12/2013

BEIJING, Nov. 12, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter financial results for for the three and nine months ended September 30, 2013.

2013 Third Quarter Financial Highlights (period-over-period comparisons to third quarter 2012)

  • Total quarterly sales increased by 54.5% to $22.1 million from $14.3 million. Excluding $3.6 million of H5N1 vaccine revenue recognized in the third quarter of 2013, the sales from regular products increased by 29.5% to $18.5 million from $14.3 million.
  • Gross profit increased by 111.7% to $15.9 million from $7.5 million. Gross margin was 72.1%, compared to 52.6%.
  • Net income attributable to common stockholders was $2.3 million, or $0.04 per basic and diluted share, compared to net loss attributed to common stockholders of $3.0 million, or $0.05 per basic and diluted share.
  • Cash and cash equivalents totaled $89.0 million as of September 30, 2013, compared to $91.2 million as of December 31, 2012.
  • Recent Business HighlightsIn August 2013, Sinovac (the "Company") was selected by the Beijing Health Bureau as one of the four suppliers to supply the Company's seasonal influenza vaccine, Anflu, to the citizens of Beijing. Sinovac has been chosen as one of the suppliers in the Beijing tender on six separate occasions since 2007. The total volume for the 2013 tender is up to 1.8 million doses and the delivery will depend on the actual demand in Beijing. Under the prior year's tender that totaled up to 1.8 million doses, Sinovac delivered approximately 340,000 doses of Anflu to Beijing citizens. 

    In October 2013, Sinovac was selected by the Jiangsu Centers for Disease Control and Prevention as one of the two suppliers of inactivated hepatitis A vaccine to the pediatric population in
    '/>"/>

    SOURCE Sinovac Biotech Ltd.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results
    2. Sinovac Reports Unaudited First Quarter 2012 Financial Results
    3. Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status
    4. Sinovac Schedules 2012 Annual Meeting of Shareholders
    5. Sinovac to Host Conference Call to Report Second Quarter 2012 Unaudited Financial Results
    6. Sinovac Reports Unaudited Second Quarter 2012 Financial Results
    7. Sinovac Holds 2012 Annual General Meeting of Shareholders
    8. Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
    9. Sinovac to Host Conference Call to Report Third Quarter 2012 Unaudited Financial Results
    10. Sinovac Reports Unaudited Third Quarter 2012 Financial Results
    11. Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/17/2015)... April 17, 2015 ASSESS shows ...   is a viable alternative to tumour biopsy   ... all patients with advanced NSCLC   AstraZeneca today ... plasma circulating tumour DNA (ctDNA) testing for epidermal growth factor ... non-small cell lung cancer (NSCLC) in clinical practice. [ ...
    (Date:4/17/2015)... YORK , April 17, 2015  Over the next ... to continue to grow, with ArcView predicting that 14 more ... legalize medical marijuana. The U.S. market for legal cannabis grew ... billion in 2013. Analysts project the market could grow more ... assuming more states soften their stance on marijuana. ...
    (Date:4/17/2015)... 2015 Research and Markets ( ... "The Corporate Reputation of Pharma - The ... report to their offering. The ... now in its fourth edition. This report contains ... For each annual Corporate Reputation report, the author ...
    Breaking Medicine Technology:"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2
    (Date:4/18/2015)... 18, 2015 Review of Ophthalmology magazine ... ‘Strategies for Success’ program for cataract surgeons attending the ... San Diego, where eye surgeon Jeffrey L. Martin, MD ... event. Dr. Martin is the Managing Partner of North ... chose Dr. Martin to lead this year’s discussion on ...
    (Date:4/18/2015)... April 18, 2015 Lowcostcarinsuranceprice.com has released ... rates have on auto insurance prices . ... rates of vehicle theft may have to pay more ... liability auto insurance policies can also offer protection against ... now be compared online on a single website: ...
    (Date:4/18/2015)... 18, 2015 Patients who undergo radiation ... mesothelioma later in life, but the disease is likely ... is unrelated to radiation. Surviving Mesothelioma has just posted ... Click here to read it now. , ... cases of 45 patients who had both a hematologic ...
    (Date:4/18/2015)... In the past few weeks, TheBeautyPlace.com has been undergoing ... to run maintenance on our shipping facilities to update ... PR Director. "It disrupted our regular shipping schedule but ... on track after having completed the maintenance." , Now, ... which has not allowed some calls to come in ...
    (Date:4/18/2015)... (PRWEB) April 18, 2015 On April 14th, ... Threat Report , which they say, “exposes a tactical shift ... new malware variants were introduced in 2014 - almost a ... Zero Day threats to be identified and patched by prominent ... abundantly clear that doing business in a digital world can ...
    Breaking Medicine News(10 mins):Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:TheBeautyPlace.com Temporary Number Available 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5
    ... is available in French . , Pediatric ... a massive boost today, following the Cole Foundation,s announcement that ... 10 Universit de Montral and four McGill University young scientists. ... and lymphomas in people under the age of 25, and ...
    ... , TUESDAY, May 17 (HealthDay News) -- A ... affect production of the pregnancy hormone progesterone and may be ... The Johns Hopkins University team looked at more than ... and identified nine who had the variation of the scavenger ...
    ... four years of remarkable progress including pioneering discoveries ... Medical Research Institute (SMRI) today announced that it will ... Institute,s Stanley Center for Psychiatric Research. Launched ... the SMRI, the Stanley Center brings together scientists from ...
    ... Mozes HealthDay Reporter , MONDAY, May 16 (HealthDay News) ... elevate "bad" cholesterol levels, and may in fact prompt a very ... , The finding comes from a six-month examination of the ... of healthy people in England. , , "The issue is that ...
    ... It is important for health care providers to report health ... there is evidence of a reluctance to share patient data ... privacy and provider confidentiality. Dr. Khaled El-Emam and his research ... protocol and system that would solve this problem. The ...
    ... by the UK journal Reproductive Health Matters shows ... the development of a vast illegal private sector with no ... became illegal in the late 1980s the number of abortions ... trade in abortions is, however, flourishing, with abortion providers advertising ...
    Cached Medicine News:Health News:Cole Foundation injects $700,000 into childhood cancer research 2Health News:Gene Variation May Explain Some Female Infertility Cases 2Health News:Grant extends funding for the Broad's Stanley Center for Psychiatric Research 2Health News:Selenium Supplements Might Give Modest Benefit Against Cholesterol 2Health News:Selenium Supplements Might Give Modest Benefit Against Cholesterol 3Health News:CHEO Research Institute develops secure protocol for data disclosure 2Health News:Abortions generate $95 million a year for Polish doctors as women use illegal private sector 2
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    Medicine Products: